OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.08
+7.17%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.41
- Revenue estimate
- $133.0K
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.38
- EPS estimate
- -$0.39
- Revenue actual
- $88.0K
- Revenue estimate
- $137.7K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +47.8%
- Revenue beats (12Q)
- 5
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026